Olaf Stüve
Neurology Section
VA North Texas Health Care System
Medical Service
Dallas VA Medical Center
Name/email consistency: high
- No Cerebral or Cervical Venous Insufficiency in US Veterans With Multiple Sclerosis. Marder, E., Gupta, P., Greenberg, B.M., Frohman, E.M., Awad, A.M., Bagert, B., Stüve, O. Arch. Neurol. (2011)
- Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet. Cravens, P.D., Hussain, R.Z., Zacharias, T.E., Ben, L.H., Herndon, E., Vinnakota, R., Lambracht-Washington, D., Nessler, S., Zamvil, S.S., Eagar, T.N., Stüve, O. J. Neuroinflammation (2011)
- Translational research in neurology and neuroscience 2010: multiple sclerosis. Stüve, O., Kieseier, B.C., Hemmer, B., Hartung, H.P., Awad, A., Frohman, E.M., Greenberg, B.M., Racke, M.K., Zamvil, S.S., Phillips, J.T., Gold, R., Chan, A., Zettl, U., Milo, R., Marder, E., Khan, O., Eagar, T.N. Arch. Neurol. (2010)
- Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms. Awad, A., Stüve, O. Ther. Adv. Neurol. Disord (2009)
- Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy. Stüve, O., Cravens, P.D., Frohman, E.M., Phillips, J.T., Remington, G.M., von Geldern, G., Cepok, S., Singh, M.P., Tervaert, J.W., De Baets, M., MacManus, D., Miller, D.H., Radü, E.W., Cameron, E.M., Monson, N.L., Zhang, S., Kim, R., Hemmer, B., Racke, M.K. Neurology (2009)
- Knowns and unknowns in the future of multiple sclerosis treatment. Stüve, O. J. Neurol. Sci. (2009)
- The effects of natalizumab on the innate and adaptive immune system in the central nervous system. Stüve, O. J. Neurol. Sci. (2008)
- DNA-based vaccines: the future of multiple sclerosis therapy? Stüve, O., Cravens, P.D., Eagar, T.N. Expert. Rev. Neurother (2008)
- Pharmacological treatment of early multiple sclerosis. Stüve, O., Bennett, J.L., Hemmer, B., Wiendl, H., Racke, M.K., Bar-Or, A., Hu, W., Zivadinov, R., Weber, M.S., Zamvil, S.S., Pacheco, M.F., Menge, T., Hartung, H.P., Kieseier, B.C., Frohman, E.M. Drugs (2008)
- alpha4-Integrin antagonism with natalizumab: effects and adverse effects. Stüve, O., Gold, R., Chan, A., Mix, E., Zettl, U., Kieseier, B.C. J. Neurol. (2008)
- Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions. Stüve, O., Marra, C.M., Cravens, P.D., Singh, M.P., Hu, W., Lovett-Racke, A., Monson, N.L., Phillips, J.T., Cohen Tervaert, J.W., Nash, R.A., Hartung, H.P., Kieseier, B.C., Racke, M.M., Frohman, E.M., Hemmer, B. Arch. Neurol. (2007)
- Immune surveillance in multiple sclerosis patients treated with natalizumab. Stüve, O., Marra, C.M., Jerome, K.R., Cook, L., Cravens, P.D., Cepok, S., Frohman, E.M., Phillips, J.T., Arendt, G., Hemmer, B., Monson, N.L., Racke, M.K. Ann. Neurol. (2006)